Spravato Billing Services

Expert Spravato Billing Services simplify claims, reduce denials, and maximize reimbursements.

Spravato billing services from A2Z cover the part of esketamine treatment that never shows up on the schedule. A visit looks simple: the patient arrives, takes the dose, and stays for observation. On the claim, it is not simple at all. The right code depends on who bought the drug and which payer is billed; the authorization has to follow the treatment calendar, and the notes have to prove two hours of monitoring. We handle that work for psychiatrists, nurse practitioner-led clinics, and interventional psychiatry practices, from the first benefit check to the last posted payment.

Why Spravato Claims Get Paid Late or Not at All

Most Spravato claim problems start before the dose is given. Five things trip practices up, and they tend to arrive together.

Spravato can sit under the medical benefit or the pharmacy benefit, and that one fact changes what you are allowed to bill.

Medicare wants one set of codes. Most other payers want another.

S0013 stopped working for dates of service starting on January 1, 2026. Some payers are still catching up. The frequency of the treatment changes over time, and an approval that was written for one phase can expire in the next phase.

Two hours of monitoring is a requirement of the program, and the note has to show it.

Esketamine billing is a problem of matching, and a mismatch in any one of these five can hold up a claim that was clinically perfect.

Spravato Billing Codes in 2026: What Goes on the Claim

The Spravato billing codes you use depend on the payer and on who supplied the drug. These four situations cover most claims.

Which Spravato Code Goes on the Claim

Situation	What goes on the claim
Medicare patient, your practice bought the drug	G2082 for up to 56 mg or G2083 for more than 56 mg. Both include the visit and the two hours of observation, and there is no separate drug line.
Commercial or Medicaid patient, your practice bought the drug	J0013 for the drug, with units equal to milligrams, plus a visit code where the payer allows one.
A REMS-certified specialty pharmacy shipped the drug	Your services only. You can bill observation and monitoring, and you cannot bill the drug.
Payer has not moved to J0013 yet.	J3490 where the payer tells you to use it, with the drug details the payer asks for.

Two warnings come with the table. Medicare does not pay J0013, so it does not belong on a Medicare claim. And the manufacturer’s coding guide says prolonged service codes 99417 and G2212 are not reported with G2082 or G2083, because those codes already include the visit.

Why S0013 claims are still bouncing

CMS replaced S0013 with J0013 on January 1, 2026. Any claim for a date of service on or after that day that still carries S0013 is rejected. Payers update their systems on their own schedules, which is why one plan accepts J0013 and the next one asks for J3490. We confirm the code with each payer before the first claim, and again whenever a claim comes back unexpectedly.

Dose, Devices and Units: The Math Behind a Session

J0013 is billed by the milligram with one unit for each milligram. Each device can hold 28 milligrams. Therefore, the number of devices equals the number of units.

Dose	Devices	J0013 units	Medicare code
28 mg	1	28	G2082
56 mg	2	56	G2082
84 mg	3	84	G2083

A units error is easy to make and slow to find. A claim that says 84 units for a patient whose note shows two devices is a denial waiting to happen. We check the device count in the note against the units on the claim before anything is sent.

Who Pays for the Drug: Your Practice or the Pharmacy

Where the drug came from decides how you bill, so we settle it before the first treatment.

When your practice buys the drug you pay for it away. You get paid back later once the insurance claim is approved. This is called buy-and-bill. It comes with a cash risk. If the approval for the drug expires between when you order it and when you give it to the patient, you might end up paying for a drug that the insurance company won’t cover. That means your practice could be stuck with the cost. For that reason, we check that the authorization is valid before each order, and not only at the start of treatment.

When a specialty pharmacy supplies the drug, the pharmacy bills for it under the pharmacy benefit. The drug may arrive at your clinic. You cannot bill for it. Observation and monitoring remain services, and that is what your claim should show.

Spravato Prior Authorization Follows the Treatment Calendar

A Spravato prior authorization is not a one-time task. The labeled schedule changes as treatment goes on. At the start,t it’s weekly sessions. After that, it becomes sessions. Then it can be weekly or every other week depending on how the treatment’s going. This means you need to keep checking in with your provider and insurance to make sure everything is approved for each phase. It’s not set and forget. It’s ongoing. An approval that covers the early weeks may not cover the later ones.

We keep track of three things, for each patient: the approved dates, the approved number of sessions,s and the approved frequency. We mark the renewal before the limit runs out so a denied claim never comes as the alert. Every request includes the diagnosis, the dose and schedule, what treatments were tried before, how the patient responded, and where the service is given. The manufacturer shares sample letters for necessity and appeals, and we use the payer’s own form whenever one is available.

A diagnosis does not guarantee approval, and we do not tell you otherwise.

The Two-Hour Observation and What It Means for Your Claim

Every Spravato session has at least two hours of observation after the dose. That time needs to be written down. It does not always mean extra money.

On Medicare claims, the observation is already included in G2082 and G2083, so there is nothing to add. On J0013 claims, some payers let you use a visit code and a prolonged service code when the time is recorded, and other payers do not. We check the payer’s policy and the note before deciding what the claim can include.

Every treatment note should show:

The exact dose and the number of devices used.

The start and end time of the observation.

Vital signs and monitoring entries during the observation.

The diagnosis matched to the labeled use.

That the patient is established, which the G-codes require.

The provider who supervised the session.

REMS Paperwork That Your Billing Depends On

Spravato is only given in a REMS-certified healthcare setting, and Spravato is always administered under observation; Spravato is never dispensed for home use. An outpatient clinic sends its setting enrollment before prescribing, enrolls each patient before treatment, and submits the patient monitoring form during treatment.

These are the clinic’s responsibilities, and we do not take them over. What we do is keep the enrollment confirmations and monitoring forms matched to the chart, so a payer question about the program has an answer ready.

A2Z's Spravato Claim Checkpoints

Spravato insurance billing at A2Z runs through the same six checkpoints on every patient.

Checkpoint	What we check	What it prevents
Benefit check	Medical or pharmacy benefit, session limits, deductible, coinsurance.	Billing the drug when a pharmacy supplied it.
Authorization	Dates, sessions, and frequency against the treatment calendar.	Sessions billed outside the approval.
Code and payer	G2082, G2083, J0013 or J3490 for this payer and this supply route.	Wrong code and retired code rejections.
Units and devices	Device count in the note against units on the claim.	Units mismatches.
Note review	Dose, observation times, vitals, supervising provider.	Questions the note cannot answer.
Follow-up	Payment against contract, open claims, and underpayments.	Claims that sit unpaid.

Spravato Claim Denials We See and How We Fix Them

Spravato claim denials follow a handful of patterns, and nearly all trace back to one of the checkpoints above.

Denial cause	What happened	How we fix it
Retired code	S0013 billed for a date of service on or after January 1, 2026.	Resubmit with the code the payer accepts, usually J0013.
Wrong code for the payer	J0013 sent to Medicare, or G2082 sent to a plan that wants a drug line.	Replace it with the code that fits the payer.
Extra codes on a G-code claim	99417 or G2212 added to G2082 or G2083.	Remove the added code.
Lapsed authorization	Sessions billed after the approved dates or beyond the approved count.	Request an extension, and appeal with the clinical record.
Units mismatch	Units on the claim do not match the devices in the note.	Correct the units and resubmit.
Drug billed when a pharmacy supplied it	A drug line on a dose the specialty pharmacy shipped.	Remove the drug line and bill only the services.
Observation not documented	A note without times or vital signs.	Get the completed note from the clinic and resubmit.

An appeal is a short packet: the denial, the policy the payer relies on, the clinical record, and a plain letter that connects them. When the same denial keeps coming back, we take it to the root cause through our denial management work.

Patient Cost Share on a High-Cost Treatment

Spravato reimbursement is only part of the revenue picture. Patients carry a deductible and coinsurance on a costly treatment, and surprise bills can end a course early.

We verify the patient’s cost share before the first dose, so the clinic can talk about it before treatment starts. Afterward, we send statements for the patient’s portion and answer billing questions, so your front desk does not have to.

Signs It Is Time to Hand Off Spravato Billing

You do not need a huge program to need help. These are the signs we hear about most.

Authorization renewals are being caught after claims are denied.

Nobody on staff is sure which code each payer wants.

Claims are paid, and nobody checks them against the contract.

Your biller is also handling every other service the practice offers.

Spravato claims sit open longer than your other claims.

If two or more of these sound familiar, outsourced Spravato billing is worth a look.

What You Keep and What We Take

When you outsource Spravato billing, the clinical side stays with your team. The paperwork and the payer work move to ours.

You keep	We take
Treatment decisions and the clinical record	Benefit checks and authorization requests
REMS enrollment and patient monitoring	Coding and units for every session
Observation and the treatment note	Claim submission and payment posting
Choosing the drug supply route	Denials, appeals and open claim follow-up

We work inside your existing EHR or practice management system under a business associate agreement, and no data migration is needed.

Who We Work With

We bill Spravato for psychiatrists, nurse practitioner-led practices, and interventional psychiatry clinics. We also work with TMS programs adding esketamine, and our TMS billing services team already knows the authorization side of that move. Our mental health billing work covers the rest of the practice.

Why Practices Pick A2Z for Spravato

A good Spravato billing company earns its place before the dose is given. This is what we put in front of you.

Payer-first coding.

The code on the claim follows the payer and the supply route, and never a default.

Calendar-aware authorizations.

We track approvals against the treatment schedule.

Records that match the claim.

Dose, devices, observation, and REMS records line up before submission.

Root cause denial work.

We fix the step that caused the denial.

Our team holds Certified Professional Biller (CPB), Certified Professional Coder (CPC), Certified Physician Practice Manager (CPPM), and Certified Professional Compliance Officer (CPCO) credentials.

Get Started with Spravato Billing

Send us a month of Spravato claims, and we will show you which ones are exposed to a denial.

Get a Free Billing Review

Frequently Asked Questions (FAQs)

Is S0013 still accepted for Spravato?

No. CMS replaced S0013 with J0013 on January 1, 2026, and claims for later dates of service that use S0013 are rejected.

Can J0013 and G2082 go on the same Medicare claim?

No. Medicare does not pay J0013, and G2082 already covers the drug, the visit, and the two hours of observation for doses up to 56 mg.

How many units do I bill for an 84 mg dose?

On J0013 claims, an 84 mg dose is 84 units, because each unit is 1 mg. On a Medicare claim, an 84 mg dose is one unit of G2083.

If a specialty pharmacy ships the drug, what do I bill?

Only your services, such as observation and monitoring. The pharmacy bills for the drug, and a clinic that bills it as well risks a denial.

Can I bill the two hours of observation separately?

On Medicare claims, no, because G2082 and G2083 include it. On J0013 claims, it depends on the payer and on what the note documents.

Does one authorization cover the whole course of Spravato?

Often it does not. Approvals commonly cover a set number of sessions or a period of time, and treatment frequency changes along the way, so we track renewals against the schedule.

Who handles REMS enrollment, the clinic or the billing company?

The clinic does. Setting enrollment, patient enrollment, and the monitoring form are clinical duties. We keep the confirmations matched to the chart.

Can you work older unpaid Spravato claims?

Yes. We can review open and denied claims through our AR follow-up and recovery work and tell you what is still collectible.